SYHA1815

SYHA1815 is a potent and selective oral RET inhibitor (IC50=0.9 nM) with antitumor activity. It functions by downregulating c-Myc, inducing G1 cell cycle arrest, and suppressing RET-driven proliferation in cellular models, supporting its investigation in RET-altered cancers.